Odabasi, Z. Et Al. 2004. beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. CLINICAL INFECTIOUS DISEASES , vol.39, no.2 , 199-205.

Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R., ... Ketchum, P.(2004). beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. CLINICAL INFECTIOUS DISEASES , vol.39, no.2, 199-205.

Odabasi, ZEKAVER Et Al. "beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome," CLINICAL INFECTIOUS DISEASES , vol.39, no.2, 199-205, 2004

Odabasi, ZEKAVER Et Al. "beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome." CLINICAL INFECTIOUS DISEASES , vol.39, no.2, pp.199-205, 2004

Odabasi, Z. Et Al. (2004) . "beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome." CLINICAL INFECTIOUS DISEASES , vol.39, no.2, pp.199-205.

@article{article, author={ZEKAVER ODABAŞI Et Al. }, title={beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome}, journal={CLINICAL INFECTIOUS DISEASES}, year=2004, pages={199-205} }